ArticlePharmaceutics2026

Moxifloxacin-Mediated Downregulation of Intestinal P-Glycoprotein Alters the Pharmacokinetics of Dabigatran Etexilate: Mechanistic Insights in Rats and PBPK Model-Informed Dose Optimization.

Yuchen Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.